Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma
2007-007091-41Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- May 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of givinostat in Hodgkin lymphoma (HL), sponsored by Italfarmaco. Primary endpoint: Objective response rate. Started May 2008; status: completed.
02
Drugs
givinostat
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2007-007091-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007091-41.